Orakl Oncology
Leveraging patient tumor avatars to transform drug development in oncology.
Cancer complexity leads to a 96% failure rate of drug candidates in clinical trials and a shortage of new treatments. Orakl Oncology’s ambition is to finally address the heterogeneity of cancer and patient specificities as early as possible in drug development.
By creating a collection of avatars of patients’ tumors, they predict how each patient will respond to future drugs, combining best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients.
Onepot
AI-native, fully automated synthesis platform that produces billions of molecules at ultra-high throughput.
Opal
Become indistractable.
Orakl Oncology
Leveraging patient tumor avatars to transform drug development in oncology.
Rivia
AI-driven analytics and data infrastructure for successful Biopharma clinical trials.
roclub
Solving the challenges of global staff shortage in healthcare with a teleoperation platform.
Second Nature
Inspiring and supporting people to live free of any lifestyle disease.
Seqera Labs
Simplifying complex data analysis pipelines in the cloud across pharma, genomics, and biotech.
The Lowdown
The UK’s leading reproductive and sexual health platform.
